Cargando…

A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity

The COVID-19 pandemic caused by SARS-CoV-2 has majorly impacted public health and economies worldwide. Although several effective vaccines and drugs are now used to prevent and treat COVID-19, natural products, especially flavonoids, showed great therapeutic potential early in the pandemic and thus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jun-Yu, Ma, Yi-Xuan, Liu, Yan, Peng, Xiang-Jun, Chen, Xiang-Zhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054335/ https://www.ncbi.nlm.nih.gov/pubmed/36985705 http://dx.doi.org/10.3390/molecules28062735

Ejemplares similares

Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD
por: Meng, Jie-Ru, et al.
Publicado: (2023)

Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2
por: Muchtaridi, Muchtaridi, et al.
Publicado: (2020)

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
por: Li, Ruofan, et al.
Publicado: (2022)

The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
por: Wang, Zhonglei, et al.
Publicado: (2023)

Flavonoids from the roots and rhizomes of Sophoratonkinensis and their in vitro anti-SARS-CoV-2 activity
por: LI, Zhuo, et al.
Publicado: (2023)

Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
por: Kaul, Ridhima, et al.
Publicado: (2021)

Inhibition of SARS-CoV 3CL protease by flavonoids
por: Jo, Seri, et al.
Publicado: (2019)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

In silico screening, SAR and kinetic studies of naturally occurring flavonoids against SARS CoV-2 main protease
por: Imran, Muhammad, et al.
Publicado: (2022)

Natural tannins as anti-SARS-CoV-2 compounds
por: Wang, Shao-Chun, et al.
Publicado: (2022)

Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
por: Jo, Seri, et al.
Publicado: (2020)

Flavonoids against the SARS-CoV-2 induced inflammatory storm
por: Liskova, Alena, et al.
Publicado: (2021)

A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
por: Singh, Ashutosh, et al.
Publicado: (2020)

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021)

Inhibition of SARS CoV Envelope Protein by Flavonoids and Classical Viroporin Inhibitors
por: Breitinger, Ulrike, et al.
Publicado: (2021)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
por: Hatmal, Ma’mon M., et al.
Publicado: (2020)

Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
por: Kim, Cheorl-Ho
Publicado: (2021)

Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2
por: Saakre, Manjesh, et al.
Publicado: (2021)

Flavonoids from Siparuna cristata as Potential Inhibitors of SARS-CoV-2 Replication
por: Leal, Carla Monteiro, et al.
Publicado: (2021)

Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication
por: Lin, Lin, et al.
Publicado: (2023)

A comprehensive survey of bat sarbecoviruses across China in relation to the origins of SARS-CoV and SARS-CoV-2
por: Wu, Zhiqiang, et al.
Publicado: (2022)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Epitope Analysis of Anti-SARS-CoV-2 Neutralizing Antibodies
por: Xue, Jun-biao, et al.
Publicado: (2021)

Gordian Knot: Gastrointestinal lesions caused by three highly pathogenic coronaviruses from SARS-CoV and MERS-CoV to SARS-CoV-2
por: Meng, Xiang, et al.
Publicado: (2021)

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma
por: Wang, Yingdan, et al.
Publicado: (2022)

An Effective Platform for SARS-CoV-2 Prevention by Combining Neutralization and RNAi Technology
por: Zhou, Jun-Xiang, et al.
Publicado: (2022)

Anti–SARS-CoV Immunoglobulin G in Healthcare Workers, Guangzhou, China
por: Chen, Wei-Qing, et al.
Publicado: (2005)

Natural Polymorphisms Are Present in the Furin Cleavage Site of the SARS-CoV-2 Spike Glycoprotein
por: Xing, Yue, et al.
Publicado: (2020)

Anti-N SARS-CoV-2 assays for evaluation of natural viral infection
por: Gaeta, Aurelia, et al.
Publicado: (2023)

Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 M(PRO)
por: Jiménez-Avalos, Gabriel, et al.
Publicado: (2021)

Comprehensive virtual screening of 4.8k flavonoids reveals novel insights into the allosteric inhibition of SARS-CoV-2 M(PRO)
por: Paula Vargas Ruiz, Ana, et al.
Publicado: (2022)

Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic
por: Wang, Ruixuan, et al.
Publicado: (2021)

Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection
por: Yi, Yang, et al.
Publicado: (2021)

In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2
por: Vijayakumar, Balaji Gowrivel, et al.
Publicado: (2020)

Comprehensive mapping of neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination
por: Chen, Xinhua, et al.
Publicado: (2021)

Anti-HIV drug repurposing against SARS-CoV-2
por: Sang, Peng, et al.
Publicado: (2020)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020)

Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS‐CoV‐2 and Other Respiratory Viruses
por: Wang, Ming, et al.
Publicado: (2020)

In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
por: Jain, Anisha S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7jpusep14fediqoqq3q540etrb